Tobón GJ - Search Results

1

Persistent and fatal severe acute respiratory syndrome coronavirus 2 infection in a patient with severe hypogammaglobulinemia: a case report.

Bedoya-Joaqui V, Gutiérrez-López MI, Caicedo PA, Villegas-Torres MF, Albornoz-Tovar LL, Vélez JD, Hidalgo-Cardona A, Tobón GJ, Cañas CA. Bedoya-Joaqui V, et al. Among authors: tobon gj. J Med Case Rep. 2023 May 13;17(1):194. doi: 10.1186/s13256-023-03917-x. J Med Case Rep. 2023. PMID: 37173711 Free PMC article.

2

Conference scene: Updating the highlights of Sjögren's syndrome.

Pers JO, Tobón GJ, Jamin C, Renaudineau Y, Youinou P. Pers JO, et al. Among authors: tobon gj. Immunotherapy. 2010 Jan;2(1):13-20. doi: 10.2217/imt.09.81. Immunotherapy. 2010. PMID: 20635887 No abstract available.

3

Are autoantibodies triggering endothelial cell apoptosis really pathogenic?

Tobón GJ, Alard JE, Youinou P, Jamin C. Tobón GJ, et al. Autoimmun Rev. 2009 Jun;8(7):605-10. doi: 10.1016/j.autrev.2009.02.005. Epub 2009 Feb 12. Autoimmun Rev. 2009. PMID: 19393202 Review.

4

Anti-cyclic citrullinated peptide antibodies in patients with primary Sjögren's syndrome.

Tobón GJ, Correa PA, Anaya JM. Tobón GJ, et al. Ann Rheum Dis. 2005 May;64(5):791-2. doi: 10.1136/ard.2004.029603. Ann Rheum Dis. 2005. PMID: 15834066 Free PMC article. No abstract available.

5

Should rituximab be considered as the first-choice treatment for severe autoimmune rheumatic diseases?

Galarza C, Valencia D, Tobón GJ, Zurita L, Mantilla RD, Pineda-Tamayo R, Rojas-Villarraga A, Rueda JC, Anaya JM. Galarza C, et al. Among authors: tobon gj. Clin Rev Allergy Immunol. 2008 Feb;34(1):124-8. doi: 10.1007/s12016-007-8028-z. Clin Rev Allergy Immunol. 2008. PMID: 18270866 Clinical Trial.

6

Emerging biotherapies for Sjögren's syndrome.

Tobón GJ, Saraux A, Pers JO, Youinou P. Tobón GJ, et al. Expert Opin Emerg Drugs. 2010 Jun;15(2):269-82. doi: 10.1517/14728211003702392. Expert Opin Emerg Drugs. 2010. PMID: 20384543 Review.

7

Autoimmune rheumatic diseases in the intensive care unit: experience from a tertiary referral hospital and review of the literature.

Camargo JF, Tobón GJ, Fonseca N, Diaz JL, Uribe M, Molina F, Anaya JM. Camargo JF, et al. Among authors: tobon gj. Lupus. 2005;14(4):315-20. doi: 10.1191/0961203305lu2082oa. Lupus. 2005. PMID: 15864918 Review.

8

The environment, geo-epidemiology, and autoimmune disease: Rheumatoid arthritis.

Tobón GJ, Youinou P, Saraux A. Tobón GJ, et al. J Autoimmun. 2010 Aug;35(1):10-4. doi: 10.1016/j.jaut.2009.12.009. Epub 2010 Jan 18. J Autoimmun. 2010. PMID: 20080387 Review.

9

B cell-targeted therapies in Sjögren's syndrome.

Tobón GJ, Pers JO, Youinou P, Saraux A. Tobón GJ, et al. Autoimmun Rev. 2010 Feb;9(4):224-8. doi: 10.1016/j.autrev.2009.08.001. Epub 2009 Aug 9. Autoimmun Rev. 2010. PMID: 19671451 Review.

10

The Fms-like tyrosine kinase 3 ligand, a mediator of B cell survival, is also a marker of lymphoma in primary Sjögren's syndrome.

Tobón GJ, Renaudineau Y, Hillion S, Cornec D, Devauchelle-Pensec V, Youinou P, Pers JO. Tobón GJ, et al. Arthritis Rheum. 2010 Nov;62(11):3447-56. doi: 10.1002/art.27611. Arthritis Rheum. 2010. PMID: 20556820 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

137 results

Search Page